Return to study ST002212 main page

MB Sample ID: SA211828

Local Sample ID:09C5
Subject ID:SU002298
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Gender:Male and female

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU002298
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Gender:Male and female

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
09C5SA211828FL025831C(Term3)Diet_phase
09C5SA211828FL025831C5Timepoint

Collection:

Collection ID:CO002291
Collection Summary:Human fecal metabolome profiles under 3 different dietary terms. During the first phase (term 1), there was no restriction on diet, but consumption of medicinal drugs and dietary supplements were prohibited. In the second phase (term 2), subjects ate provided meals. The menus of meals were different every time. For the last phase (term 3), subjects continuously ate an identical meal 15 times, three times a day over 5 days. Commercially available box meals, frozen foods, fruits, sandwiches, rice balls, retort foods were provided in term 2 and 3. Throughout the trial, subjects collected their feces and froze them as soon as they could. After which, the frozen fecal samples were shipped frozen to the Institute for Advanced Biosciences, Keio University, Yamagata, Japan, for metabolome and metagenome analysis.
Sample Type:Feces

Treatment:

Treatment ID:TR002310
Treatment Summary:Human fecal metabolome profiles under 3 different dietary terms. During the first phase (term 1), there was no restriction on diet, but consumption of medicinal drugs and dietary supplements were prohibited. In the second phase (term 2), subjects ate provided meals. The menus of meals were different every time. For the last phase (term 3), subjects continuously ate an identical meal 15 times, three times a day over 5 days. Commercially available box meals, frozen foods, fruits, sandwiches, rice balls, retort foods were provided in term 2 and 3. Throughout the trial, subjects collected their feces and froze them as soon as they could. After which, the frozen fecal samples were shipped frozen to the Institute for Advanced Biosciences, Keio University, Yamagata, Japan, for metabolome and metagenome analysis.

Sample Preparation:

Sampleprep ID:SP002304
Sampleprep Summary:Fecal samples were freeze-dried, and then metabolites were extracted using the methanol:chloroform:water extraction protocol.

Combined analysis:

Analysis ID AN003616 AN003617
Analysis type MS MS
Chromatography type CE CE
Chromatography system Agilent CE Agilent CE
Column Fused-silica,50um(cation) COSMO(+),50um(anion
MS Type ESI ESI
MS instrument type Other Other
MS instrument name Agilent CE-TOFMS Agilent CE-TOFMS
Ion Mode POSITIVE NEGATIVE
Units μmol/g μmol/g

Chromatography:

Chromatography ID:CH002671
Instrument Name:Agilent CE
Column Name:Fused-silica,50um(cation)
Internal Standard:Methionine sulfone
Chromatography Type:CE
  
Chromatography ID:CH002672
Instrument Name:Agilent CE
Column Name:COSMO(+),50um(anion
Internal Standard:D-camphor-10-sulfonic acid
Chromatography Type:CE

MS:

MS ID:MS003367
Analysis ID:AN003616
Instrument Name:Agilent CE-TOFMS
Instrument Type:Other
MS Type:ESI
MS Comments:In-house software (MasterHands) was used for peak area integration and annotation.
Ion Mode:POSITIVE
  
MS ID:MS003368
Analysis ID:AN003617
Instrument Name:Agilent CE-TOFMS
Instrument Type:Other
MS Type:ESI
MS Comments:In-house software (MasterHands) was used for peak area integration and annotation.
Ion Mode:NEGATIVE
  logo